Retina Implant AG lands reimbursement from Germany's statutory health insurance system to cover its Alpha IMS microchip for helping correct vision.
Retina Implant AG announced this week that it won reimbursement from Germany's government health system to cover the company's flagship Alpha IMS microchip, an implantable device for helping to correct vision in patients with late-stage retinitis pigmentosa (RP).
The reimbursement win is Retina Implant's 1st in the world, coming from the company's home country.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sJEcW6
Cap comentari:
Publica un comentari a l'entrada